OQS
OLMA icon

Occudo Quantitative Strategies’s Olema Pharmaceuticals OLMA Stock Holding History

Occudo Quantitative Strategies’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-17,917
Closed -$162K – 1213
2023
Q2 		$162K Buy
+17,917
New +$108K 0.02% 884
2023
Q1 		– Sell
-16,322
Closed -$40K – 1112
2022
Q4 		$40K Sell
16,322
-3,330
-17% -$9.71K ﹤0.01% 892
2022
Q3 		$54K Sell
19,652
-21,294
-52% -$90.3K ﹤0.01% 1085
2022
Q2 		$167K Sell
40,946
-18,878
-32% -$59.9K 0.01% 949
2022
Q1 		$255K Sell
59,824
-17,379
-23% -$95.8K 0.02% 871
2021
Q4 		$723K Buy
+77,203
New +$1.6M 0.06% 480

Other funds holding OLMA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Occudo Quantitative Strategies's OLMA Position: Q3 2023 in Review

Occudo Quantitative Strategies sold out of Olema Pharmaceuticals (OLMA) in Q3 2023, closing a stake of 17,917 shares — an estimated $162K sold.

Occudo Quantitative Strategies first reported a position in OLMA in Q4 2021 and held it in 6 quarters. The position peaked at $723K in Q4 2021. 97 funds tracked by Wall St. Rank hold OLMA as of Q3 2023.

  • Occudo Quantitative Strategies reported no remaining Olema Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 17,917 Olema Pharmaceuticals shares in Q3 2023, an estimated $162K.
  • Occudo Quantitative Strategies first reported a position in Olema Pharmaceuticals in Q4 2021 and held it in 6 quarters.
  • Occudo Quantitative Strategies's Olema Pharmaceuticals position peaked at $723K in Q4 2021.
  • 97 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q3 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.